Symbol:
Gpr155
Name:
G protein-coupled receptor 155
RGD ID:
1309162
Description:
Predicted to enable cholesterol binding activity. Predicted to be involved in several processes, including cellular response to amino acid starvation; cellular response to cholesterol; and regulation of signal transduction. Predicted to be active in lysosomal membrane. Orthologous to human GPR155 (G protein-coupled receptor 155); INTERACTS WITH (+)-schisandrin B; 1,2-dimethylhydrazine; 17beta-estradiol.
Type:
protein-coding
RefSeq Status:
PROVISIONAL
Previously known as:
integral membrane protein GPR155; LOC311730
RGD Orthologs
Alliance Orthologs
More Info
more info ...
More Info
Latest Assembly:
GRCr8 - GRCr8 Assembly
Position:
Rat Assembly Chr Position (strand) Source Genome Browsers JBrowse NCBI UCSC Ensembl GRCr8 3 78,623,931 - 78,677,803 (-) NCBI GRCr8 mRatBN7.2 3 58,216,422 - 58,270,350 (-) NCBI mRatBN7.2 mRatBN7.2 mRatBN7.2 Ensembl 3 58,216,423 - 58,270,275 (-) Ensembl mRatBN7.2 Ensembl UTH_Rnor_SHR_Utx 3 61,608,714 - 61,663,736 (-) NCBI Rnor_SHR UTH_Rnor_SHR_Utx UTH_Rnor_SHRSP_BbbUtx_1.0 3 70,192,372 - 70,247,396 (-) NCBI Rnor_SHRSP UTH_Rnor_SHRSP_BbbUtx_1.0 UTH_Rnor_WKY_Bbb_1.0 3 67,957,385 - 68,012,414 (-) NCBI Rnor_WKY UTH_Rnor_WKY_Bbb_1.0 Rnor_6.0 3 60,051,545 - 60,105,567 (-) NCBI Rnor6.0 Rnor_6.0 rn6 Rnor6.0 Rnor_6.0 Ensembl 3 60,051,535 - 60,105,242 (-) Ensembl Rnor6.0 rn6 Rnor6.0 Rnor_5.0 3 66,535,458 - 66,589,249 (-) NCBI Rnor5.0 Rnor_5.0 rn5 Rnor5.0 RGSC_v3.4 3 55,846,337 - 55,900,086 (-) NCBI RGSC3.4 RGSC_v3.4 rn4 RGSC3.4 RGSC_v3.1 3 55,744,673 - 55,791,771 (-) NCBI Celera 3 57,751,878 - 57,798,023 (-) NCBI Celera Cytogenetic Map 3 q23 NCBI
JBrowse:
View Region in Genome Browser (JBrowse)
Model
Only show annotations with direct experimental evidence (0 objects hidden)
Gpr155 Rat (+)-schisandrin B multiple interactions EXP 6480464 schizandrin B inhibits the reaction [Carbon Tetrachloride results in decreased expression of GPR155 mRNA] CTD PMID:31150632 Gpr155 Rat (1->4)-beta-D-glucan multiple interactions ISO RGD:1319349 6480464 [perfluorooctane sulfonic acid co-treated with Cellulose] results in increased expression of GPR155 mRNA CTD PMID:36331819 Gpr155 Rat 1,2-dimethylhydrazine multiple interactions EXP 6480464 [APC protein affects the susceptibility to 1,2-Dimethylhydrazine] which results in increased expression of GPR155 mRNA CTD PMID:27840820 Gpr155 Rat 1,2-dimethylhydrazine decreases expression ISO RGD:1319349 6480464 1,2-Dimethylhydrazine results in decreased expression of GPR155 mRNA CTD PMID:22206623 Gpr155 Rat 17beta-estradiol multiple interactions ISO RGD:1319348 6480464 [Estradiol co-treated with Progesterone] results in decreased expression of GPR155 mRNA CTD PMID:20660070 Gpr155 Rat 17beta-estradiol decreases expression ISO RGD:1319349 6480464 Estradiol results in decreased expression of GPR155 mRNA CTD PMID:39298647 Gpr155 Rat 17beta-estradiol decreases expression EXP 6480464 Estradiol results in decreased expression of GPR155 mRNA CTD PMID:32145629 Gpr155 Rat 2,3,7,8-tetrachlorodibenzodioxine decreases expression ISO RGD:1319349 6480464 Tetrachlorodibenzodioxin results in decreased expression of GPR155 mRNA CTD PMID:17337447|PMID:19933214 Gpr155 Rat 2,3,7,8-tetrachlorodibenzodioxine affects expression ISO RGD:1319349 6480464 Tetrachlorodibenzodioxin affects the expression of GPR155 mRNA CTD PMID:21570461|PMID:26377647 Gpr155 Rat 2,3,7,8-tetrachlorodibenzodioxine affects expression EXP 6480464 Tetrachlorodibenzodioxin affects the expression of GPR155 mRNA CTD PMID:22298810 Gpr155 Rat 2,4-dinitrotoluene affects expression EXP 6480464 2,4-dinitrotoluene affects the expression of GPR155 mRNA CTD PMID:21346803 Gpr155 Rat 3,3',4,4'-tetrachlorobiphenyl multiple interactions ISO RGD:1319349 6480464 3,4,3',4'-tetrachlorobiphenyl inhibits the reaction [Dietary Fats results in increased expression of GPR155 mRNA] CTD PMID:19467301 Gpr155 Rat 3-isobutyl-1-methyl-7H-xanthine multiple interactions ISO RGD:1319348 6480464 [INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol A] more ... CTD PMID:28628672 Gpr155 Rat 4,4'-sulfonyldiphenol decreases expression ISO RGD:1319349 6480464 bisphenol S results in decreased expression of GPR155 mRNA CTD PMID:39298647 Gpr155 Rat 4-hydroxyphenyl retinamide decreases expression ISO RGD:1319349 6480464 Fenretinide results in decreased expression of GPR155 mRNA CTD PMID:28973697 Gpr155 Rat 4-hydroxyphenyl retinamide increases expression ISO RGD:1319349 6480464 Fenretinide results in increased expression of GPR155 mRNA CTD PMID:28973697 Gpr155 Rat 6-propyl-2-thiouracil decreases expression EXP 6480464 Propylthiouracil results in decreased expression of GPR155 mRNA CTD PMID:30047161 Gpr155 Rat aflatoxin B1 decreases expression ISO RGD:1319349 6480464 Aflatoxin B1 results in decreased expression of GPR155 mRNA CTD PMID:19770486 Gpr155 Rat aflatoxin B1 decreases methylation ISO RGD:1319348 6480464 Aflatoxin B1 results in decreased methylation of GPR155 intron CTD PMID:30157460 Gpr155 Rat all-trans-retinoic acid increases expression ISO RGD:1319348 6480464 Tretinoin results in increased expression of GPR155 mRNA CTD PMID:23724009 Gpr155 Rat all-trans-retinoic acid decreases expression ISO RGD:1319348 6480464 Tretinoin results in decreased expression of GPR155 mRNA CTD PMID:33167477 Gpr155 Rat amphetamine decreases expression EXP 6480464 Amphetamine results in decreased expression of GPR155 mRNA CTD PMID:30779732 Gpr155 Rat arsane affects methylation ISO RGD:1319348 6480464 Arsenic affects the methylation of GPR155 gene CTD PMID:25304211 Gpr155 Rat arsenic atom affects methylation ISO RGD:1319348 6480464 Arsenic affects the methylation of GPR155 gene CTD PMID:25304211 Gpr155 Rat atrazine affects methylation EXP 6480464 Atrazine affects the methylation of GPR155 gene CTD PMID:28931070 Gpr155 Rat benzo[a]pyrene increases methylation ISO RGD:1319348 6480464 Benzo(a)pyrene results in increased methylation of GPR155 5' UTR CTD PMID:27901495 Gpr155 Rat beta-lapachone decreases expression ISO RGD:1319348 6480464 beta-lapachone results in decreased expression of GPR155 mRNA CTD PMID:38218311 Gpr155 Rat bisphenol A multiple interactions EXP 6480464 [bisphenol A co-treated with Testosterone] results in increased expression of GPR155 mRNA; [bisphenol A co-treated more ... CTD PMID:26496021|PMID:31129395 Gpr155 Rat bisphenol A decreases expression ISO RGD:1319349 6480464 bisphenol A results in decreased expression of GPR155 mRNA CTD PMID:32156529 Gpr155 Rat bisphenol A increases expression ISO RGD:1319349 6480464 bisphenol A results in increased expression of GPR155 mRNA CTD PMID:33221593 Gpr155 Rat bisphenol A increases methylation EXP 6480464 bisphenol A results in increased methylation of GPR155 gene CTD PMID:28505145 Gpr155 Rat bisphenol A multiple interactions ISO RGD:1319348 6480464 [INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol A] more ... CTD PMID:28628672 Gpr155 Rat bisphenol A decreases expression EXP 6480464 bisphenol A results in decreased expression of GPR155 mRNA CTD PMID:25181051|PMID:32145629 Gpr155 Rat cadmium atom multiple interactions ISO RGD:1319348 6480464 [Cadmium Chloride results in increased abundance of Cadmium] which results in increased expression of GPR155 more ... CTD PMID:35301059 Gpr155 Rat cadmium dichloride decreases expression ISO RGD:1319348 6480464 Cadmium Chloride results in decreased expression of GPR155 mRNA CTD PMID:38568856 Gpr155 Rat cadmium dichloride multiple interactions ISO RGD:1319348 6480464 [Cadmium Chloride results in increased abundance of Cadmium] which results in increased expression of GPR155 more ... CTD PMID:35301059 Gpr155 Rat carbon nanotube decreases expression ISO RGD:1319349 6480464 Nanotubes, Carbon results in decreased expression of GPR155 mRNA CTD PMID:25554681 Gpr155 Rat choline multiple interactions ISO RGD:1319349 6480464 [Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in increased methylation more ... CTD PMID:20938992 Gpr155 Rat ciguatoxin CTX1B affects expression ISO RGD:1319349 6480464 Ciguatoxins affects the expression of GPR155 mRNA CTD PMID:18353800 Gpr155 Rat cisplatin increases expression ISO RGD:1319348 6480464 Cisplatin results in increased expression of GPR155 mRNA CTD PMID:27392435 Gpr155 Rat Cuprizon decreases expression EXP 6480464 Cuprizone results in decreased expression of GPR155 mRNA CTD PMID:26577399 Gpr155 Rat cyclosporin A decreases expression ISO RGD:1319349 6480464 Cyclosporine results in decreased expression of GPR155 mRNA CTD PMID:19770486 Gpr155 Rat dexamethasone multiple interactions ISO RGD:1319348 6480464 [INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol A] more ... CTD PMID:28628672 Gpr155 Rat Dibutyl phosphate affects expression ISO RGD:1319348 6480464 di-n-butylphosphoric acid affects the expression of GPR155 mRNA CTD PMID:37042841 Gpr155 Rat dioxygen multiple interactions ISO RGD:1319349 6480464 [NFE2L2 protein affects the susceptibility to Oxygen] which affects the expression of GPR155 mRNA CTD PMID:30529165 Gpr155 Rat dioxygen multiple interactions EXP 6480464 [Oxygen deficiency co-treated with Blood Glucose deficiency co-treated with Particulate Matter] results in decreased expression more ... CTD PMID:33729688 Gpr155 Rat dorsomorphin multiple interactions ISO RGD:1319348 6480464 [NOG protein co-treated with Phenylmercuric Acetate co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased more ... CTD PMID:27188386 Gpr155 Rat entinostat increases expression ISO RGD:1319348 6480464 entinostat results in increased expression of GPR155 mRNA CTD PMID:27188386 Gpr155 Rat epoxiconazole decreases expression ISO RGD:1319349 6480464 epoxiconazole results in decreased expression of GPR155 mRNA CTD PMID:35436446 Gpr155 Rat ethanol affects splicing ISO RGD:1319349 6480464 Ethanol affects the splicing of GPR155 mRNA CTD PMID:30319688 Gpr155 Rat ethanol affects expression ISO RGD:1319349 6480464 Ethanol affects the expression of GPR155 mRNA CTD PMID:30319688 Gpr155 Rat ethyl methanesulfonate increases expression ISO RGD:1319348 6480464 Ethyl Methanesulfonate results in increased expression of GPR155 mRNA CTD PMID:23649840 Gpr155 Rat fenthion decreases expression ISO RGD:1319349 6480464 Fenthion results in decreased expression of GPR155 mRNA CTD PMID:34813904 Gpr155 Rat folic acid multiple interactions ISO RGD:1319349 6480464 [Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in increased methylation more ... CTD PMID:20938992 Gpr155 Rat hydroquinone decreases expression ISO RGD:1319348 6480464 hydroquinone results in decreased expression of GPR155 mRNA CTD PMID:31256213 Gpr155 Rat hydroquinone O-beta-D-glucopyranoside decreases expression ISO RGD:1319348 6480464 Arbutin results in decreased expression of GPR155 mRNA CTD PMID:17103032 Gpr155 Rat indometacin multiple interactions ISO RGD:1319348 6480464 [INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol A] more ... CTD PMID:28628672 Gpr155 Rat inulin multiple interactions ISO RGD:1319349 6480464 [perfluorooctane sulfonic acid co-treated with Inulin] results in increased expression of GPR155 mRNA CTD PMID:36331819 Gpr155 Rat L-methionine multiple interactions ISO RGD:1319349 6480464 [Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in increased methylation more ... CTD PMID:20938992 Gpr155 Rat lead diacetate increases expression ISO RGD:1319349 6480464 lead acetate results in increased expression of GPR155 mRNA CTD PMID:21829687 Gpr155 Rat lead(0) affects expression ISO RGD:1319348 6480464 Lead affects the expression of GPR155 mRNA CTD PMID:28903495 Gpr155 Rat lipopolysaccharide multiple interactions ISO RGD:1319348 6480464 [S-(1,2-dichlorovinyl)cysteine affects the susceptibility to Lipopolysaccharides] which results in increased expression of GPR155 mRNA CTD PMID:35811015 Gpr155 Rat methimazole decreases expression EXP 6480464 Methimazole results in decreased expression of GPR155 mRNA CTD PMID:30047161 Gpr155 Rat methyl methanesulfonate increases expression ISO RGD:1319348 6480464 Methyl Methanesulfonate results in increased expression of GPR155 mRNA CTD PMID:23649840 Gpr155 Rat N,N-diethyl-m-toluamide multiple interactions EXP 6480464 [Permethrin co-treated with DEET] results in increased methylation of GPR155 gene CTD PMID:33148267 Gpr155 Rat N-methyl-4-phenylpyridinium increases expression ISO RGD:1319348 6480464 1-Methyl-4-phenylpyridinium results in increased expression of GPR155 mRNA CTD PMID:24810058 Gpr155 Rat nitrofen decreases expression EXP 6480464 nitrofen results in decreased expression of GPR155 mRNA CTD PMID:26720608 Gpr155 Rat paracetamol affects expression ISO RGD:1319349 6480464 Acetaminophen affects the expression of GPR155 mRNA CTD PMID:17562736 Gpr155 Rat paracetamol increases expression EXP 6480464 Acetaminophen results in increased expression of GPR155 mRNA CTD PMID:33387578 Gpr155 Rat paraquat decreases expression EXP 6480464 Paraquat results in decreased expression of GPR155 mRNA CTD PMID:32680482 Gpr155 Rat pentane-2,3-dione decreases expression EXP 6480464 2,3-pentanedione results in decreased expression of GPR155 mRNA CTD PMID:25710175 Gpr155 Rat perfluorooctane-1-sulfonic acid multiple interactions ISO RGD:1319349 6480464 [perfluorooctane sulfonic acid co-treated with Cellulose] results in increased expression of GPR155 mRNA; [perfluorooctane sulfonic more ... CTD PMID:36331819 Gpr155 Rat perfluorooctanoic acid decreases expression EXP 6480464 perfluorooctanoic acid results in decreased expression of GPR155 mRNA CTD PMID:35163327 Gpr155 Rat permethrin multiple interactions EXP 6480464 [Permethrin co-treated with DEET] results in increased methylation of GPR155 gene CTD PMID:33148267 Gpr155 Rat phenylmercury acetate increases expression ISO RGD:1319348 6480464 Phenylmercuric Acetate results in increased expression of GPR155 mRNA CTD PMID:26272509 Gpr155 Rat phenylmercury acetate multiple interactions ISO RGD:1319348 6480464 [NOG protein co-treated with Phenylmercuric Acetate co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased more ... CTD PMID:27188386 Gpr155 Rat pirinixic acid decreases expression ISO RGD:1319349 6480464 pirinixic acid results in decreased expression of GPR155 mRNA CTD PMID:23811191 Gpr155 Rat progesterone multiple interactions ISO RGD:1319348 6480464 [Estradiol co-treated with Progesterone] results in decreased expression of GPR155 mRNA CTD PMID:20660070 Gpr155 Rat propanal increases expression ISO RGD:1319348 6480464 propionaldehyde results in increased expression of GPR155 mRNA CTD PMID:26079696 Gpr155 Rat propiconazole decreases expression ISO RGD:1319349 6480464 propiconazole results in decreased expression of GPR155 mRNA CTD PMID:21278054 Gpr155 Rat resveratrol multiple interactions ISO RGD:1319348 6480464 [Plant Extracts co-treated with Resveratrol] results in increased expression of GPR155 mRNA CTD PMID:23557933 Gpr155 Rat S-(1,2-dichlorovinyl)-L-cysteine multiple interactions ISO RGD:1319348 6480464 [S-(1,2-dichlorovinyl)cysteine affects the susceptibility to Lipopolysaccharides] which results in increased expression of GPR155 mRNA CTD PMID:35811015 Gpr155 Rat SB 431542 multiple interactions ISO RGD:1319348 6480464 [NOG protein co-treated with Phenylmercuric Acetate co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased more ... CTD PMID:27188386 Gpr155 Rat silicon dioxide decreases expression ISO RGD:1319349 6480464 Silicon Dioxide results in decreased expression of GPR155 mRNA CTD PMID:19073995|PMID:23221170 Gpr155 Rat silicon dioxide decreases expression ISO RGD:1319348 6480464 Silicon Dioxide analog results in decreased expression of GPR155 mRNA CTD PMID:25895662 Gpr155 Rat silver atom decreases expression ISO RGD:1319348 6480464 Silver results in decreased expression of GPR155 mRNA CTD PMID:28959546 Gpr155 Rat silver(0) decreases expression ISO RGD:1319348 6480464 Silver results in decreased expression of GPR155 mRNA CTD PMID:28959546 Gpr155 Rat sodium fluoride decreases expression EXP 6480464 Sodium Fluoride results in decreased expression of GPR155 mRNA CTD PMID:27257137 Gpr155 Rat succimer multiple interactions ISO RGD:1319349 6480464 [Succimer binds to Magnetite Nanoparticles] which results in decreased expression of GPR155 mRNA CTD PMID:21641980 Gpr155 Rat sulfadimethoxine decreases expression EXP 6480464 Sulfadimethoxine results in decreased expression of GPR155 mRNA CTD PMID:30047161 Gpr155 Rat testosterone multiple interactions EXP 6480464 [bisphenol A co-treated with Testosterone] results in increased expression of GPR155 mRNA CTD PMID:26496021 Gpr155 Rat testosterone multiple interactions ISO RGD:1319349 6480464 1,2-dibromo-4-(1,2-dibromoethyl)cyclohexane inhibits the reaction [Testosterone deficiency results in decreased expression of GPR155 mRNA] CTD PMID:33848595 Gpr155 Rat testosterone decreases expression ISO RGD:1319349 6480464 Testosterone deficiency results in decreased expression of GPR155 mRNA CTD PMID:33848595 Gpr155 Rat tetrachloromethane affects expression ISO RGD:1319349 6480464 Carbon Tetrachloride affects the expression of GPR155 mRNA CTD PMID:17484886 Gpr155 Rat tetrachloromethane decreases expression EXP 6480464 Carbon Tetrachloride results in decreased expression of GPR155 mRNA CTD PMID:31150632 Gpr155 Rat tetrachloromethane multiple interactions EXP 6480464 schizandrin B inhibits the reaction [Carbon Tetrachloride results in decreased expression of GPR155 mRNA] CTD PMID:31150632 Gpr155 Rat tetrachloromethane decreases expression ISO RGD:1319349 6480464 Carbon Tetrachloride results in decreased expression of GPR155 mRNA CTD PMID:27339419|PMID:31919559 Gpr155 Rat thiram decreases expression ISO RGD:1319348 6480464 Thiram results in decreased expression of GPR155 mRNA CTD PMID:38568856 Gpr155 Rat titanium dioxide decreases expression ISO RGD:1319349 6480464 titanium dioxide results in decreased expression of GPR155 mRNA CTD PMID:23557971 Gpr155 Rat titanium dioxide decreases methylation ISO RGD:1319349 6480464 titanium dioxide results in decreased methylation of GPR155 promoter CTD PMID:35295148 Gpr155 Rat tributylstannane multiple interactions EXP 6480464 [bisphenol A co-treated with tributyltin] results in increased expression of GPR155 mRNA CTD PMID:31129395 Gpr155 Rat trichloroethene increases expression EXP 6480464 Trichloroethylene results in increased expression of GPR155 mRNA CTD PMID:33387578 Gpr155 Rat trichostatin A affects expression ISO RGD:1319348 6480464 trichostatin A affects the expression of GPR155 mRNA CTD PMID:28542535 Gpr155 Rat triclosan increases expression ISO RGD:1319348 6480464 Triclosan results in increased expression of GPR155 mRNA CTD PMID:30510588 Gpr155 Rat triphenyl phosphate affects expression ISO RGD:1319348 6480464 triphenyl phosphate affects the expression of GPR155 mRNA CTD PMID:37042841 Gpr155 Rat trovafloxacin decreases expression ISO RGD:1319349 6480464 trovafloxacin results in decreased expression of GPR155 mRNA CTD PMID:35537566 Gpr155 Rat valproic acid affects expression ISO RGD:1319348 6480464 Valproic Acid affects the expression of GPR155 mRNA CTD PMID:25979313 Gpr155 Rat valproic acid multiple interactions ISO RGD:1319348 6480464 [NOG protein co-treated with Valproic Acid co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased more ... CTD PMID:27188386 Gpr155 Rat valproic acid increases expression ISO RGD:1319348 6480464 Valproic Acid results in increased expression of GPR155 mRNA CTD PMID:23179753|PMID:24383497|PMID:24935251|PMID:26272509|PMID:27188386|PMID:28001369|PMID:29154799
(+)-schisandrin B (EXP) (1->4)-beta-D-glucan (ISO) 1,2-dimethylhydrazine (EXP,ISO) 17beta-estradiol (EXP,ISO) 2,3,7,8-tetrachlorodibenzodioxine (EXP,ISO) 2,4-dinitrotoluene (EXP) 3,3',4,4'-tetrachlorobiphenyl (ISO) 3-isobutyl-1-methyl-7H-xanthine (ISO) 4,4'-sulfonyldiphenol (ISO) 4-hydroxyphenyl retinamide (ISO) 6-propyl-2-thiouracil (EXP) aflatoxin B1 (ISO) all-trans-retinoic acid (ISO) amphetamine (EXP) arsane (ISO) arsenic atom (ISO) atrazine (EXP) benzo[a]pyrene (ISO) beta-lapachone (ISO) bisphenol A (EXP,ISO) cadmium atom (ISO) cadmium dichloride (ISO) carbon nanotube (ISO) choline (ISO) ciguatoxin CTX1B (ISO) cisplatin (ISO) Cuprizon (EXP) cyclosporin A (ISO) dexamethasone (ISO) Dibutyl phosphate (ISO) dioxygen (EXP,ISO) dorsomorphin (ISO) entinostat (ISO) epoxiconazole (ISO) ethanol (ISO) ethyl methanesulfonate (ISO) fenthion (ISO) folic acid (ISO) hydroquinone (ISO) hydroquinone O-beta-D-glucopyranoside (ISO) indometacin (ISO) inulin (ISO) L-methionine (ISO) lead diacetate (ISO) lead(0) (ISO) lipopolysaccharide (ISO) methimazole (EXP) methyl methanesulfonate (ISO) N,N-diethyl-m-toluamide (EXP) N-methyl-4-phenylpyridinium (ISO) nitrofen (EXP) paracetamol (EXP,ISO) paraquat (EXP) pentane-2,3-dione (EXP) perfluorooctane-1-sulfonic acid (ISO) perfluorooctanoic acid (EXP) permethrin (EXP) phenylmercury acetate (ISO) pirinixic acid (ISO) progesterone (ISO) propanal (ISO) propiconazole (ISO) resveratrol (ISO) S-(1,2-dichlorovinyl)-L-cysteine (ISO) SB 431542 (ISO) silicon dioxide (ISO) silver atom (ISO) silver(0) (ISO) sodium fluoride (EXP) succimer (ISO) sulfadimethoxine (EXP) testosterone (EXP,ISO) tetrachloromethane (EXP,ISO) thiram (ISO) titanium dioxide (ISO) tributylstannane (EXP) trichloroethene (EXP) trichostatin A (ISO) triclosan (ISO) triphenyl phosphate (ISO) trovafloxacin (ISO) valproic acid (ISO)
Gpr155 Rat Assembly Chr Position (strand) Source Genome Browsers JBrowse NCBI UCSC Ensembl GRCr8 3 78,623,931 - 78,677,803 (-) NCBI GRCr8 mRatBN7.2 3 58,216,422 - 58,270,350 (-) NCBI mRatBN7.2 mRatBN7.2 mRatBN7.2 Ensembl 3 58,216,423 - 58,270,275 (-) Ensembl mRatBN7.2 Ensembl UTH_Rnor_SHR_Utx 3 61,608,714 - 61,663,736 (-) NCBI Rnor_SHR UTH_Rnor_SHR_Utx UTH_Rnor_SHRSP_BbbUtx_1.0 3 70,192,372 - 70,247,396 (-) NCBI Rnor_SHRSP UTH_Rnor_SHRSP_BbbUtx_1.0 UTH_Rnor_WKY_Bbb_1.0 3 67,957,385 - 68,012,414 (-) NCBI Rnor_WKY UTH_Rnor_WKY_Bbb_1.0 Rnor_6.0 3 60,051,545 - 60,105,567 (-) NCBI Rnor6.0 Rnor_6.0 rn6 Rnor6.0 Rnor_6.0 Ensembl 3 60,051,535 - 60,105,242 (-) Ensembl Rnor6.0 rn6 Rnor6.0 Rnor_5.0 3 66,535,458 - 66,589,249 (-) NCBI Rnor5.0 Rnor_5.0 rn5 Rnor5.0 RGSC_v3.4 3 55,846,337 - 55,900,086 (-) NCBI RGSC3.4 RGSC_v3.4 rn4 RGSC3.4 RGSC_v3.1 3 55,744,673 - 55,791,771 (-) NCBI Celera 3 57,751,878 - 57,798,023 (-) NCBI Celera Cytogenetic Map 3 q23 NCBI
GPR155 Human Assembly Chr Position (strand) Source Genome Browsers JBrowse NCBI UCSC Ensembl GRCh38 2 174,431,571 - 174,487,029 (-) NCBI GRCh38 GRCh38 hg38 GRCh38 GRCh38.p14 Ensembl 2 174,431,571 - 174,487,094 (-) Ensembl GRCh38 hg38 GRCh38 GRCh37 2 175,296,299 - 175,351,757 (-) NCBI GRCh37 GRCh37 hg19 GRCh37 Build 36 2 175,004,621 - 175,060,057 (-) NCBI NCBI36 Build 36 hg18 NCBI36 Build 34 2 175,124,852 - 175,177,315 NCBI Celera 2 168,909,805 - 168,965,228 (-) NCBI Celera Cytogenetic Map 2 q31.1 NCBI HuRef 2 167,176,854 - 167,232,645 (-) NCBI HuRef CHM1_1 2 175,302,416 - 175,357,917 (-) NCBI CHM1_1 T2T-CHM13v2.0 2 174,920,213 - 174,975,693 (-) NCBI T2T-CHM13v2.0
Gpr155 Mouse Assembly Chr Position (strand) Source Genome Browsers JBrowse NCBI UCSC Ensembl GRCm39 2 73,171,850 - 73,216,842 (-) NCBI GRCm39 GRCm39 mm39 GRCm39 Ensembl 2 73,171,850 - 73,216,916 (-) Ensembl GRCm39 Ensembl GRCm38 2 73,341,506 - 73,386,521 (-) NCBI GRCm38 GRCm38 mm10 GRCm38 GRCm38.p6 Ensembl 2 73,341,506 - 73,386,572 (-) Ensembl GRCm38 mm10 GRCm38 MGSCv37 2 73,179,564 - 73,224,455 (-) NCBI GRCm37 MGSCv37 mm9 NCBIm37 MGSCv36 2 73,142,346 - 73,187,411 (-) NCBI MGSCv36 mm8 Celera 2 75,028,084 - 75,072,976 (-) NCBI Celera Cytogenetic Map 2 C3 NCBI cM Map 2 43.59 NCBI
Gpr155 Chinchilla Assembly Chr Position (strand) Source Genome Browsers JBrowse NCBI UCSC Ensembl ChiLan1.0 Ensembl NW_004955449 889,590 - 930,146 (+) Ensembl ChiLan1.0 ChiLan1.0 NW_004955449 889,657 - 930,146 (+) NCBI ChiLan1.0 ChiLan1.0
GPR155 Bonobo Assembly Chr Position (strand) Source Genome Browsers JBrowse NCBI UCSC Ensembl NHGRI_mPanPan1-v2 13 77,098,845 - 77,151,110 (-) NCBI NHGRI_mPanPan1-v2 NHGRI_mPanPan1 2B 77,113,820 - 77,166,072 (-) NCBI NHGRI_mPanPan1 Mhudiblu_PPA_v0 2B 61,710,094 - 61,764,434 (-) NCBI Mhudiblu_PPA_v0 Mhudiblu_PPA_v0 panPan3 PanPan1.1 2B 179,166,785 - 179,218,301 (-) NCBI panpan1.1 PanPan1.1 panPan2 PanPan1.1 Ensembl 2B 179,166,785 - 179,218,301 (-) Ensembl panpan1.1 panPan2
GPR155 Dog Assembly Chr Position (strand) Source Genome Browsers JBrowse NCBI UCSC Ensembl CanFam3.1 36 18,481,269 - 18,524,733 (-) NCBI CanFam3.1 CanFam3.1 canFam3 CanFam3.1 CanFam3.1 Ensembl 36 18,482,910 - 18,520,192 (-) Ensembl CanFam3.1 canFam3 CanFam3.1 Dog10K_Boxer_Tasha 36 18,490,301 - 18,533,981 (-) NCBI Dog10K_Boxer_Tasha ROS_Cfam_1.0 36 18,616,992 - 18,660,430 (-) NCBI ROS_Cfam_1.0 ROS_Cfam_1.0 Ensembl 36 18,616,995 - 18,660,433 (-) Ensembl ROS_Cfam_1.0 Ensembl UMICH_Zoey_3.1 36 18,694,132 - 18,737,537 (-) NCBI UMICH_Zoey_3.1 UNSW_CanFamBas_1.0 36 18,692,674 - 18,736,267 (-) NCBI UNSW_CanFamBas_1.0 UU_Cfam_GSD_1.0 36 18,803,433 - 18,846,862 (-) NCBI UU_Cfam_GSD_1.0
Gpr155 Squirrel Assembly Chr Position (strand) Source Genome Browsers JBrowse NCBI UCSC Ensembl HiC_Itri_2 NW_024405303 135,648,684 - 135,724,814 (-) NCBI HiC_Itri_2 SpeTri2.0 Ensembl NW_004936509 4,204,362 - 4,252,949 (-) Ensembl SpeTri2.0 SpeTri2.0 Ensembl SpeTri2.0 NW_004936509 4,202,587 - 4,252,865 (-) NCBI SpeTri2.0 SpeTri2.0 SpeTri2.0
GPR155 Pig Assembly Chr Position (strand) Source Genome Browsers JBrowse NCBI UCSC Ensembl Sscrofa11.1 Ensembl 15 80,396,976 - 80,462,018 (-) Ensembl Sscrofa11.1 susScr11 Sscrofa11.1 Sscrofa11.1 15 80,417,247 - 80,462,091 (-) NCBI Sscrofa11.1 Sscrofa11.1 susScr11 Sscrofa11.1 Sscrofa10.2 15 89,588,500 - 89,700,017 (-) NCBI Sscrofa10.2 Sscrofa10.2 susScr3
GPR155 Green Monkey Assembly Chr Position (strand) Source Genome Browsers JBrowse NCBI UCSC Ensembl ChlSab1.1 10 59,941,613 - 59,993,896 (-) NCBI ChlSab1.1 ChlSab1.1 chlSab2 ChlSab1.1 Ensembl 10 59,945,483 - 59,989,998 (-) Ensembl ChlSab1.1 ChlSab1.1 Ensembl chlSab2 Vero_WHO_p1.0 NW_023666040 139,600,873 - 139,652,734 (+) NCBI Vero_WHO_p1.0 Vero_WHO_p1.0
Gpr155
.
Predicted Target Of
Count of predictions: 281 Count of miRNA genes: 186 Interacting mature miRNAs: 224 Transcripts: ENSRNOT00000025158 Prediction methods: Miranda, Targetscan Result types: miRGate_prediction
1582238 Bw68 Body weight QTL 68 3.2 0.0064 body mass (VT:0001259) body weight (CMO:0000012) 3 53184593 115665732 Rat 1582239 Epfw1 Epididymal fat weight QTL 1 4.5 0.0006 epididymal fat pad mass (VT:0010421) epididymal fat pad weight to body weight ratio (CMO:0000658) 3 53184593 115665732 Rat 2298542 Neuinf11 Neuroinflammation QTL 11 3.9 nervous system integrity trait (VT:0010566) spinal cord complement component 1, q subcomponent, B chain mRNA level (CMO:0002126) 3 15005422 76927699 Rat 1358362 Srcrt2 Stress Responsive Cort QTL 2 2.78 blood corticosterone amount (VT:0005345) plasma corticosterone level (CMO:0001173) 3 38192233 133483320 Rat 737818 Hcar12 Hepatocarcinoma resistance QTL 12 2.6 liver integrity trait (VT:0010547) volume of individual liver tumorous lesion (CMO:0001078) 3 29463235 118376539 Rat 1582218 Bw74 Body weight QTL 74 3.9 0.0021 body mass (VT:0001259) body weight (CMO:0000012) 3 53184593 115665732 Rat 1581568 Rf53 Renal function QTL 53 urine total protein amount (VT:0000032) urine protein excretion rate to body weight ratio (CMO:0001099) 3 56395968 161299569 Rat 9590286 Uminl1 Urine mineral level QTL 1 3.5 0.001 urine mineral amount (VT:0015086) urine electrolyte level (CMO:0000593) 3 28249687 73249687 Rat 724523 Tsu1 Thymus enlargement suppressive QTL 1 3.84 thymus mass (VT:0004954) thymus weight to body weight ratio (CMO:0000612) 3 50437504 115638231 Rat 1581503 Cm58 Cardiac mass QTL 58 2.7 0.05 heart left ventricle mass (VT:0007031) heart left ventricle weight to body weight ratio (CMO:0000530) 3 43827364 121056321 Rat 2292613 Ept16 Estrogen-induced pituitary tumorigenesis QTL 16 8.3 pituitary gland mass (VT:0010496) pituitary gland wet weight (CMO:0000853) 3 47233430 110362260 Rat 731180 Bp152 Blood pressure QTL 152 0.03 arterial blood pressure trait (VT:2000000) mean arterial blood pressure (CMO:0000009) 3 53781112 91609953 Rat 61356 Bp37 Blood pressure QTL 37 3 blood pressure trait (VT:0000183) systolic blood pressure (CMO:0000004) 3 30684642 75684642 Rat 1358905 Hrtrt17 Heart rate QTL 17 5.9 0.000014 heart pumping trait (VT:2000009) heart rate (CMO:0000002) 3 10861912 89878372 Rat 8694196 Abfw2 Abdominal fat weight QTL 2 16.58 0.001 visceral adipose mass (VT:0010063) abdominal fat pad weight to body weight ratio (CMO:0000095) 3 28249687 73249687 Rat 2301971 Cm71 Cardiac mass QTL 71 4.63 heart left ventricle mass (VT:0007031) heart left ventricle weight (CMO:0000776) 3 41874578 155617519 Rat 1358885 Bp251 Blood pressure QTL 251 3.8 arterial blood pressure trait (VT:2000000) mean arterial blood pressure (CMO:0000009) 3 14489145 121056321 Rat 2301970 Bw81 Body weight QTL 81 5.19 body mass (VT:0001259) body weight (CMO:0000012) 3 41874578 155617519 Rat 1582249 Bw77 Body weight QTL 77 3.2 0.0025 epididymal fat pad mass (VT:0010421) epididymal fat pad weight to body weight ratio (CMO:0000658) 3 53184593 64655484 Rat 2290452 Scl56 Serum cholesterol level QTL 56 2.26 blood cholesterol amount (VT:0000180) plasma total cholesterol level (CMO:0000585) 3 1 91609953 Rat 12879868 Am6 Aortic mass QTL 6 0.001 aorta mass (VT:0002845) aorta weight to aorta length to body weight ratio (CMO:0002722) 3 31426403 70668733 Rat 11565451 Bw177 Body weight QTL 177 0.002 body mass (VT:0001259) body weight (CMO:0000012) 3 31426403 70668733 Rat 1358888 Bp264 Blood pressure QTL 264 4.43 arterial blood pressure trait (VT:2000000) mean arterial blood pressure (CMO:0000009) 3 14489145 121056321 Rat 11565452 Kidm57 Kidney mass QTL 57 0.001 kidney mass (VT:0002707) both kidneys wet weight to body weight ratio (CMO:0000340) 3 31426403 70668733 Rat 12879866 Cm94 Cardiac mass QTL 94 0.001 heart left ventricle mass (VT:0007031) heart left ventricle weight to body weight ratio (CMO:0000530) 3 31426403 70668733 Rat 12879867 Cm95 Cardiac mass QTL 95 0.047 heart right ventricle mass (VT:0007033) heart right ventricle weight to body weight ratio (CMO:0000914) 3 31426403 70668733 Rat 1300178 Hrtrt4 Heart rate QTL 4 3.74 heart pumping trait (VT:2000009) heart rate (CMO:0000002) 3 43827364 90905114 Rat 61377 Edpm3 Estrogen-dependent pituitary mass QTL 3 7.05 0.038 pituitary gland mass (VT:0010496) pituitary gland wet weight (CMO:0000853) 3 53184692 89878207 Rat 2302055 Pia30 Pristane induced arthritis QTL 30 3.5 0.001 blood autoantibody amount (VT:0003725) serum immunoglobulin M-type rheumatoid factor level relative to an arbitrary reference serum (CMO:0002111) 3 27936919 72936919 Rat 1331795 Rf30 Renal function QTL 30 3.708 urine potassium amount (VT:0010539) urine potassium level (CMO:0000128) 3 39454637 89115240 Rat 70216 Cm14 Cardiac mass QTL 14 2.1 heart mass (VT:0007028) heart wet weight (CMO:0000069) 3 31172320 163586636 Rat 1354589 Bw31 Body weight QTL 31 3.3 body mass (VT:0001259) body weight (CMO:0000012) 3 33703347 78196190 Rat 2303593 Gluco46 Glucose level QTL 46 3 blood glucose amount (VT:0000188) blood glucose level (CMO:0000046) 3 28468571 73468571 Rat 1354590 Despr11 Despair related QTL 11 0.000031 locomotor behavior trait (VT:0001392) amount of experiment time spent in a discrete space in an experimental apparatus (CMO:0000958) 3 28468571 73468571 Rat 2292591 Esta4 Estrogen-induced thymic atrophy QTL 4 thymus mass (VT:0004954) thymus wet weight (CMO:0000855) 3 47233211 147415807 Rat 1331777 Bw24 Body weight QTL 24 3.503 body mass (VT:0001259) body weight (CMO:0000012) 3 39454637 89115240 Rat 631647 Bp122 Blood pressure QTL 122 6.2 arterial blood pressure trait (VT:2000000) systolic blood pressure (CMO:0000004) 3 30684642 75684642 Rat 1300169 Bp177 Blood pressure QTL 177 2.96 arterial blood pressure trait (VT:2000000) blood pressure time series experimental set point of the baroreceptor response (CMO:0002593) 3 33703347 61017857 Rat 1559282 Emca5 Estrogen-induced mammary cancer QTL 5 3.9 mammary gland integrity trait (VT:0010552) percentage of study population developing mammary tumors during a period of time (CMO:0000948) 3 43827364 169034231 Rat 2302276 Bw82 Body weight QTL 82 4.32 body mass (VT:0001259) body weight (CMO:0000012) 3 39454637 62951183 Rat 738019 Anxrr10 Anxiety related response QTL 10 3.9 exploratory behavior trait (VT:0010471) number of entries into a discrete space in an experimental apparatus (CMO:0000960) 3 38517803 83517803 Rat 9590136 Scort3 Serum corticosterone level QTL 3 23.37 0.001 blood corticosterone amount (VT:0005345) plasma corticosterone level (CMO:0001173) 3 28249687 73249687 Rat 10450804 Scl70 Serum cholesterol level QTL 70 4.7 0.001 blood LDL cholesterol amount (VT:0000181) blood low density lipoprotein cholesterol level (CMO:0000053) 3 20714090 65714090 Rat 61419 Cia11 Collagen induced arthritis QTL 11 5.6 joint integrity trait (VT:0010548) joint inflammation composite score (CMO:0000919) 3 30356773 98535386 Rat 1354597 Kidm13 Kidney mass QTL 13 2.9 kidney mass (VT:0002707) right kidney wet weight (CMO:0000082) 3 41874578 104104347 Rat 8552950 Pigfal12 Plasma insulin-like growth factor 1 level QTL 12 7.3 blood insulin-like growth factor amount (VT:0010479) plasma insulin-like growth factor 1 level (CMO:0001299) 3 28249687 73249687 Rat 631676 Cm8 Cardiac mass QTL 8 7.03 0.0001 aorta mass (VT:0002845) aorta weight (CMO:0000076) 3 16954708 61954708 Rat 10450794 Scl69 Serum cholesterol level QTL 69 6.3 0.001 blood LDL cholesterol amount (VT:0000181) blood low density lipoprotein cholesterol level (CMO:0000053) 3 20714090 65714090 Rat 8694386 Bw159 Body weight QTL 159 4.52 0.001 body lean mass (VT:0010483) lean tissue morphological measurement (CMO:0002184) 3 28249687 73249687 Rat 1354604 Bw36 Body weight QTL 36 2.9 body mass (VT:0001259) body weight (CMO:0000012) 3 33703347 104104347 Rat 631665 Bw8 Body weight QTL 8 5.5 body mass (VT:0001259) body weight (CMO:0000012) 3 50437042 119183768 Rat 2301400 Cm68 Cardiac mass QTL 68 0.001 heart mass (VT:0007028) heart wet weight to body weight ratio (CMO:0002408) 3 31426403 70668733 Rat 1358186 Ept2 Estrogen-induced pituitary tumorigenesis QTL 2 8.3 pituitary gland mass (VT:0010496) pituitary gland wet weight (CMO:0000853) 3 47233430 110362260 Rat
BE106553
Rat Assembly Chr Position (strand) Source JBrowse mRatBN7.2 3 58,262,093 - 58,262,252 (+) MAPPER mRatBN7.2 Rnor_6.0 3 60,097,073 - 60,097,231 NCBI Rnor6.0 Rnor_5.0 3 66,580,986 - 66,581,144 UniSTS Rnor5.0 RGSC_v3.4 3 55,892,028 - 55,892,186 UniSTS RGSC3.4 Celera 3 57,789,966 - 57,790,124 UniSTS Cytogenetic Map 3 q22-q23 UniSTS
RH127769
Rat Assembly Chr Position (strand) Source JBrowse mRatBN7.2 3 58,216,516 - 58,216,733 (+) MAPPER mRatBN7.2 Rnor_6.0 3 60,051,640 - 60,051,856 NCBI Rnor6.0 Rnor_5.0 3 66,535,553 - 66,535,769 UniSTS Rnor5.0 RGSC_v3.4 3 55,846,431 - 55,846,647 UniSTS RGSC3.4 Celera 3 57,751,972 - 57,752,188 UniSTS Cytogenetic Map 3 q22-q23 UniSTS
RH139072
Rat Assembly Chr Position (strand) Source JBrowse mRatBN7.2 3 58,265,441 - 58,265,578 (+) MAPPER mRatBN7.2 Rnor_6.0 3 60,100,409 - 60,100,545 NCBI Rnor6.0 Rnor_5.0 3 66,584,110 - 66,584,246 UniSTS Rnor5.0 RGSC_v3.4 3 55,895,253 - 55,895,389 UniSTS RGSC3.4 Celera 3 57,793,190 - 57,793,326 UniSTS Cytogenetic Map 3 q22-q23 UniSTS
Click on a value in the shaded box below the category label to view a detailed expression data table for that system.
alimentary part of gastrointestinal system
9
11
49
113
91
90
59
25
59
6
218
97
93
45
60
31
Too many to show, limit is 500. Download them if you would like to view them all.
Ensembl Acc Id:
ENSRNOT00000025158 ⟹ ENSRNOP00000025158
Type:
CODING
Position:
Rat Assembly Chr Position (strand) Source mRatBN7.2 Ensembl 3 58,216,423 - 58,270,275 (-) Ensembl Rnor_6.0 Ensembl 3 60,051,546 - 60,105,242 (-) Ensembl
Ensembl Acc Id:
ENSRNOT00000086329 ⟹ ENSRNOP00000071125
Type:
CODING
Position:
Rat Assembly Chr Position (strand) Source mRatBN7.2 Ensembl 3 58,216,423 - 58,270,275 (-) Ensembl Rnor_6.0 Ensembl 3 60,051,535 - 60,105,212 (-) Ensembl
RefSeq Acc Id:
NM_001107811 ⟹ NP_001101281
RefSeq Status:
PROVISIONAL
Type:
CODING
Position:
Rat Assembly Chr Position (strand) Source GRCr8 3 78,623,932 - 78,677,803 (-) NCBI mRatBN7.2 3 58,216,423 - 58,270,275 (-) NCBI Rnor_6.0 3 60,051,546 - 60,105,242 (-) NCBI Rnor_5.0 3 66,535,458 - 66,589,249 (-) NCBI RGSC_v3.4 3 55,846,337 - 55,900,086 (-) RGD Celera 3 57,751,878 - 57,798,023 (-) RGD
Sequence:
AGGTACCCGGCCGCAGACGCCTAAGGTAGCTGACAGGCCCGCAGCGGCTCACCCCTCCCTTTTCTCGGAACGTGGTTGGGCATCTGCTGCTGGCTCAAGCCTTTAGAAGAGGGCTCCGGGCAGGAGAT
hide sequence
RefSeq Acc Id:
XM_006234356 ⟹ XP_006234418
Type:
CODING
Position:
Rat Assembly Chr Position (strand) Source GRCr8 3 78,623,931 - 78,673,085 (-) NCBI mRatBN7.2 3 58,218,606 - 58,270,346 (-) NCBI Rnor_6.0 3 60,053,781 - 60,105,567 (-) NCBI Rnor_5.0 3 66,535,458 - 66,589,249 (-) NCBI
Sequence:
GGCTGTGTGGGAGGGCCTCGGGTACCGGGGGCGGAGCGCTGTCGCTTGTCCTTGGGGGCGGGGCCTAAGGGCGAGGAGGGGACCCGCATTCCGACCTTCTGGCTAGGGGCGGGTCCCTTGGTGGGGCC
hide sequence
RefSeq Acc Id:
XM_006234357 ⟹ XP_006234419
Type:
CODING
Position:
Rat Assembly Chr Position (strand) Source GRCr8 3 78,629,126 - 78,673,085 (-) NCBI mRatBN7.2 3 58,221,628 - 58,270,345 (-) NCBI Rnor_6.0 3 60,056,751 - 60,105,281 (-) NCBI Rnor_5.0 3 66,535,458 - 66,589,249 (-) NCBI
Sequence:
CCAGGGGCGGGGCCTGAAGGCGGGGCGGAGGCGGGGAGGAGGTACCCGGCCGCAGACGCCTAAG
hide sequence
RefSeq Acc Id:
XM_039105161 ⟹ XP_038961089
Type:
CODING
Position:
Rat Assembly Chr Position (strand) Source GRCr8 3 78,627,731 - 78,673,085 (-) NCBI mRatBN7.2 3 58,221,212 - 58,270,350 (-) NCBI
RefSeq Acc Id:
NP_001101281 ⟸ NM_001107811
- UniProtKB:
D3ZWM3 (UniProtKB/TrEMBL), A6HM90 (UniProtKB/TrEMBL), A0A0G2JZP1 (UniProtKB/TrEMBL)
- Sequence:
MDSYFPAKNSTLAVNMNETLSASHGFNSTSDPPPMSITRLFPALLECFGIVLCGYIAGRANVITSTQAKGLGNFVSRFALPALLFKNMVVLNFANVDWAFLYSILIGKASVFFVVCVLTLLVASPESR
hide sequence
RefSeq Acc Id:
XP_006234418 ⟸ XM_006234356
- Peptide Label:
isoform X2
- UniProtKB:
A6HM92 (UniProtKB/TrEMBL)
- Sequence:
MDSYFPAKNSTLAVNMNETLSASHGFNSTSDPPPMSITRLFPALLECFGIVLCGYIAGRANVITSTQAKGLGNFVSRFALPALLFKNMVVLNFANVDWAFLYSILIGKASVFFVVCVLTLLVASPESR
hide sequence
RefSeq Acc Id:
XP_006234419 ⟸ XM_006234357
- Peptide Label:
isoform X3
- UniProtKB:
A6HM91 (UniProtKB/TrEMBL), A6HM92 (UniProtKB/TrEMBL)
- Sequence:
MDSYFPAKNSTLAVNMNETLSASHGFNSTSDPPPMSITRLFPALLECFGIVLCGYIAGRANVIT
hide sequence
Ensembl Acc Id:
ENSRNOP00000071125 ⟸ ENSRNOT00000086329
Ensembl Acc Id:
ENSRNOP00000025158 ⟸ ENSRNOT00000025158
RefSeq Acc Id:
XP_038961089 ⟸ XM_039105161
- Peptide Label:
isoform X1
- UniProtKB:
A6HM92 (UniProtKB/TrEMBL)
RGD ID: 13692150 Promoter ID: EPDNEW_R2670 Type: initiation region Name: Gpr155_1 Description: G protein-coupled receptor 155 SO ACC ID: SO:0000170 Source: EPDNEW (Eukaryotic Promoter Database, http://epd.vital-it.ch/ ) Experiment Methods: Single-end sequencing. Position: Rat Assembly Chr Position (strand) Source Rnor_6.0 3 60,105,138 - 60,105,198 EPDNEW
Date
Current Symbol
Current Name
Previous Symbol
Previous Name
Description
Reference
Status
2008-04-30
Gpr155
G protein-coupled receptor 155
Gpr155_predicted
G protein-coupled receptor 155 (predicted)
'predicted' is removed
2292626 APPROVED
2005-01-12
Gpr155_predicted
G protein-coupled receptor 155 (predicted)
Symbol and Name status set to approved
70820 APPROVED
